Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 3,4-dimethoxyphenyl-benzo[d]oxazole as a tumor resistance reversal agent

A drug resistance reversal and tumor technology, which is applied in the direction of antineoplastic drugs, medical preparations containing active ingredients, drug combinations, etc., can solve the problems such as the complex formation mechanism of MDR, and achieve the effect of improving drug resistance of tumor cells

Active Publication Date: 2021-05-11
无锡享源信息科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The formation mechanism of MDR is complex, in which the overexpression of ABC drug transport pump is the main reason for mediating MDR

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3,4-dimethoxyphenyl-benzo[d]oxazole as a tumor resistance reversal agent
  • Application of 3,4-dimethoxyphenyl-benzo[d]oxazole as a tumor resistance reversal agent
  • Application of 3,4-dimethoxyphenyl-benzo[d]oxazole as a tumor resistance reversal agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] In this example, the compound 4,6-di-tert-butyl-2-(3,4-dimethoxyphenyl)benzo[d]oxazole-7-ol (CAS: 175881- 00-2) as an example to illustrate its application as a transport pump inhibitor.

[0039] Cell culture: H460 / MX20 (non-small cell lung cancer drug-resistant cell line with high ABCG2 expression) was cultured in DMEM medium containing 10% fetal bovine serum and 1% penicillin-streptomycin, and the cells were maintained at 37°C containing 5 %CO 2 in a humid incubator.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention specifically relates to the application of 3,4-dimethoxyphenyl-benzo[d]oxazole as a tumor drug resistance reversal agent. In the late stage of tumor treatment, the main reason for the failure of chemotherapy regimens comes from the drug resistance of tumor cells. Existing related studies have shown that the cause of drug resistance in tumor cells is related to drug transporters. The research of the present invention shows that 4,6-di-tert-butyl-2-(3,4-dimethoxyphenyl)benzo[d]oxazole-7-ol can inhibit the transport-related proteins in tumor cells and reverse the Drug resistance can improve the sensitivity of tumor cells to anti-tumor drugs, and can be used as an adjuvant therapy for chemotherapy regimens and co-administered with other anti-tumor drugs, which has good clinical significance.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to 3,4-dimethoxyphenyl-benzo[d]oxazole compounds——4,6-di-tert-butyl-2-(3,4-dimethoxy The application of phenyl) benzo [d] oxazole-7-ol as tumor resistance reversal agent, and the 4,6-di-tert-butyl-2-(3,4-dimethoxyphenyl ) Application of the pharmaceutical composition of benzo[d]oxazole-7-ol in the preparation of antitumor agents. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] The high mortality rate of malignant tumors is often associated with drug resistance in the late stage of cancer, especially multidrug resistance (MDR). MDR refers to the cross-resistance of t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/423A61K31/136A61P35/00A61P35/02C07D263/57
CPCA61K31/136A61K31/423A61P35/00A61P35/02C07D263/57A61K2300/00
Inventor 卢佳澳盛卸晃类红旭赵子婧
Owner 无锡享源信息科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products